GlobeNewswire Inc | Oct 14, 2021 04:30PM EDT

October 14, 2021

SAN DIEGO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2021 financial results on Thursday, October 28, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information Date: Thursday, October 28, 2021Time: 4:30 p.m. ETDial-in +1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)numbers:Confirmation 5068414code:Live webcast: Travere.com in the ?Events & Presentations? section of the ?Investors? page

A replay of the call will be available from 7:30 p.m. ET, October 28, 2021 to 7:30 p.m. ET, November 4, 2021. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 5068414.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope today and tomorrow. For more information, visit travere.com

Contact:Chris Cline, CFASenior Vice President, Investor Relations & Corporate Communications888-969-7879IR@travere.com